Keywords: Glycotope, Biobetter, Roche, Herceptin, Breast cancer, Trastuzumab

Glycotope enrolls first patient for “biobetter” of Roche cancer drug Herceptin

Article | 20 September 2011

Print This

Berlin, Germany-based glycomics specialist Glycotope GmbH says it has enrolled the first patients in a Phase I dose finding trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in